Symbol="VINC"
AssetType="Common Stock"
Name="Vincerx Pharma Inc"
Description="Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company is headquartered in Palo Alto, California."
CIK="1796129"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="REAL ESTATE & CONSTRUCTION"
Industry="BLANK CHECKS"
Address="250 W 55TH ST #3401, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="23557300"
EBITDA="-64524000"
PERatio="None"
PEGRatio="None"
BookValue="1.622"
DividendPerShare="0"
DividendYield="0"
EPS="-2.33"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.533"
ReturnOnEquityTTM="-1.024"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.33"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.228"
EVToRevenue="-"
EVToEBITDA="0.673"
Beta="0.29"
num_52WeekHigh="1.95"
num_52WeekLow="0.631"
num_50DayMovingAverage="1.487"
num_200DayMovingAverage="1.17"
SharesOutstanding="21245800"
DividendDate="None"
ExDividendDate="None"
symbol="VINC"
open="1.18"
high="1.18"
low="1.07"
price="1.07"
volume="70459.00"
latest_trading_day="2023-07-27"
previous_close="1.15"
change="-0.08"
change_percent="-6.9565%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="28"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="72"
Volume_recent_avg="73199"
Change_recent_avg="-0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="72"
Aroon_momentum_negative="28"
image_negative_thumbnail_id_1="509"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_negative_thumbnail_id_2="1148"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_neutral_thumbnail_id_1="595"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_neutral_thumbnail_id_2="544"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_positive_thumbnail_id_1="653"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0055.jpeg"
image_positive_thumbnail_id_2="688"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
